PRKAB1 Knockout HAP1 Cell Line
Cat.No.:
EDC07889
Species:
Human
Cell Name:
HAP1
Gene:
PRKAB1
Gene ID:
5564
Size:
1×10⁶cells
PRKAB1 Knockout HAP1 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07889 |
|---|---|
| Product Name | PRKAB1 Knockout HAP1 Cell Line |
| Species | Human |
| Cell Line | HAP1 |
| Cellosaurus ID | CVCL_0F62 |
| Gene ID | |
| Cell Line Synonyms | Highly Aggressively Proliferating Immortalized |
| Gene | PRKAB1 |
| Summary |
The protein encoded by this gene is a regulatory subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This subunit may be a positive regulator of AMPK activity. The myristoylation and phosphorylation of this subunit have been shown to affect the enzyme activity and cellular localization of AMPK. This subunit may also serve as an adaptor molecule mediating the association of the AMPK complex. [provided by RefSeq, Jul 2008]
|
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | IMDM+10%FBS |
| Freezing Medium | 90%FBS+10%DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
FAQ
Which is better for studying PRKAB1 function, PRKAB1 Knockout HAP1 Cell Line or PRKAB1 overexpression HAP1 Cell Line?
The choice depends on whether you are studying PRKAB1 (AMPKβ1)'s role as a regulatory subunit of AMP-activated protein kinase or its specific contributions distinct from AMPKβ2 (PRKAB2). The Knockout line is appropriate for asking whether AMPKβ1 is required for AMPK heterotrimer assembly and downstream signaling — β1 and β2 confer tissue-specific AMPK targeting and contain the carbohydrate-binding module (CBM) and AMPKα-binding scaffold. Overexpression is useful for studying β1-specific AMPK functions or for testing direct AMPK activators.
For AMPK research, the EDITGENE PRKAB1 Knockout in HAP1 enables study of β1-specific AMPK functions. PRKAB2 (AMPKβ2) paralog expression should be assessed — combined β1 + β2 loss is needed for complete AMPK functional disruption. Rescue with wild-type or CBM-mutant AMPKβ1 enables structure-function studies. The knockout is relevant for testing AMPKβ1-selective direct activators (PF-06409577 and related metformin-mimetic compounds in development for metabolic disease).
What are the application scenarios for this model?
Primary applications:
• AMPK heterotrimer assembly: co-immunoprecipitation of α and γ subunits to assess AMPK complex integrity in the absence of β1.
• AMPK activity in response to energy stress: phospho-AMPKα (T172) and phospho-ACC (S79) following glucose deprivation, AICAR, or metformin treatment.
• β1-selective activator pharmacology: critical genetic control for AMPKβ1-selective direct activators (PF-06409577 and related compounds) — these activators target the ADaM site between α and β subunits.
• Paralog studies: PRKAB2 expression analysis to assess β1 versus β2 functional specialization.
EDITGENE recommends this model for researchers investigating AMPK regulatory subunit biology and β1-selective AMPK activator pharmacology.
Is this PRKAB1 Knockout HAP1 Cell Line compatible with overexpression rescue experiments?
Yes. AMPKβ1 rescue experiments require attention to heterotrimer assembly:
• Construct design: use a codon-modified PRKAB1 sequence with a small C-terminal tag (FLAG, HA). AMPKβ1 has N-terminal myristoylation site, carbohydrate-binding module (CBM), and C-terminal α/γ-binding domain — preserve all elements.
• CBM-mutant rescue: glycogen binding-deficient mutations enable studies of glycogen-mediated AMPK regulation.
• Myristoylation-deficient rescue: G2A mutation abolishes membrane targeting and enables studies of membrane-localized versus cytoplasmic AMPK functions.
• Functional readout: rescue should restore AMPK heterotrimer formation, T172 phosphorylation, and substrate phosphorylation.
HAP1-specific considerations:
• Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay.
• Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended.
• Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download